| Phase 1 (baseline) n= 53 | Phase 2 (intervention) n= 47 | Phase 3 (adjustment) n= 43 | Phase 4 (consolidation) n= 50 | P 1-2 | P 1-3 | P 1-4 |
---|---|---|---|---|---|---|---|
Age (years), median (IQR) | 64 (54; 74) | 65 (49; 74) | 61 (49; 67) | 61 (51;69) | 0.87 | 0.10 | 0.24 |
Female Sex, n (%) | 19 (36%) | 18 (38%) | 12 (28%) | 13 (26%) | 0.84 | 0.51 | 0.30 |
SAPS II, median (IQR) | 41 (31; 54) | 38 (27; 53) | 34 (27; 41) | 37 (26; 53) | 0.64 | 0.07 | 0.57 |
Surgical admission*, n (%) | 22 (42%) | 25 (53%) | 16 (37%) | 26 (52%) | 0.32 | 0.29 | 0.33 |
Mechanical ventilation, n (%) | 24 (45%) | 21 (45%) | 13 (30%) | 22 (45%) | 0.95 | 0.13 | 0.90 |
Sustained use of sedatives, n (%) | 22 (42%) | 15 (32%) | 9 (21%) | 14 (29%) | 0.32 | 0.03 | 0.15 |
RASS level, median (IQR) | 0 (-3; 0) | 0 (-1; 0) | 0 (0; 0) | 0 (-1; 0) | 0.92 | 0.52 | 0.41 |
Number of procedures evaluated per patient, median (IQR) | 2 (1; 4) | 2 (1; 3) | 3 (1; 5) | 3 (3; 3) | 0.39 | 0.38 | 0.24 |